AmCad BioMed is the world’s first medical device company to receive FDA approval for its ultrasound computer-aided diagnosis (CAD) system. Combining AI and clinical expertise, AmCad has developed four FDA, CE, and TFDA-certified AI-assisted CAD software, including AmCAD-UT for thyroid nodule detection and AmCAD-UO for rapid OSA assessment. Driven by innovation, AmCad’s patented technologies have earned numerous accolades, empowering healthcare professionals with enhanced diagnostic quality and superior patient experiences. A pioneer in ultrasound AI, AmCad redefines diagnostic precision and patient care.
Ambry Genetics
Ambry Genetics, a wholly owned subsidiary of Tempus, translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing and aims to improve health by understanding the relationship between genetics and disease. Over its 25-year history, Ambry has remained committed to empowering patients to make informed healthcare decisions based on their genetic data.
Altamont Software
Altamont Software enhances medical imaging workflow through the company’s Connectivity Platform—an integrated, enterprise infrastructure—supporting a comprehensive suite of document, eForm, and video capture applications. Designed for simplicity, the platform enables centralized management, seamless configuration, and efficient deployment while ensuring enterprise-level security and scalability. Learn how we can help you connect, communicate, and consolidate many of your medical imaging workflows at www.altamont.com.
AlphaSense
AlphaSense is a market intelligence and search platform used by the world’s leading companies and financial institutions. Since 2011, our AI-based technology has helped professionals make smarter business decisions by delivering insights from an extensive universe of public and private content—including company filings, event transcripts, expert calls, news, trade journals, and equity research. Our platform is trusted by over 3,500 enterprise customers, including a majority of the S&P 500. Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Germany, Finland, and India. For more information, please visit www.alpha-sense.com. | The world’s most sophisticated companies rely on AlphaSense to remove uncertainty from decision-making. With market intelligence and search built on proven AI, AlphaSense delivers insights that matter from content you can trust. Our universe of public and private content includes equity research, company filings, event transcripts, expert calls, news, trade journals, and clients’ own research content. Founded in 2011, AlphaSense is headquartered in New York City with over 1,000 people across the globe and offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com. | AlphaSense is how the world’s most sophisticated companies remove uncertainty from their decision-making. With market intelligence and search built on proven AI, AlphaSense quickly delivers relevant insights from a trustworthy universe of public and private content—including equity research, company filings, event transcripts, expert calls, news, trade journals, and clients’ own research content. Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com. | AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit www.alpha-sense.com. | AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows.
Almac Group
Almac Diagnostic Services We are a precision medicine company specialising in biomarker driven clinical trials. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions. Our cores services: * Multi-Omic Services: We offer a range of genomic & proteomic platform and chemistry options, alongside expert data sciences support & a specialty central lab service. * Clinical Biomarker & CDx Development: Custom Clinical Biomarker & CDx development, validation & delivery service from our CLIA & CAP accredited laboratories in USA, Europe and APAC. * Clinical Testing: Global clinical trial testing service from our clinical laboratories, including a menu of platforms & assays and an integrated specimen collection & logistics service. Find Out More www.almacgroup.com/diagnostics | The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Almac possesses a wealth of technical expertise to support the delivery of your complex projects. Our scientists can develop your clinical candidate into an optimum formulation, and solid manufacture oral dose products for all stages of clinical trials. Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. We specialise in the manufacture & primary packaging of solid, oral dosage forms (Tablets, Capsules and Powders). As well as customised secondary packaging for all drug products including ultra-low temperature drug products. Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options. | Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Providing end-to-end integrated solutions to bring your drug product from development through to commercialisation from a single source. We work with clients to provide pharmaceutical development, manufacturing, product launch, and packaging solutions to fit their unique needs. Our team of experts can support the development of fit-for-purpose formulation for First-in-Human trials, to developing a more robust formulations scaling up for late phase trials, and ultimately commercialisation. Supporting key development and manufacture areas such as paediatrics, potent and highly potent products. We provide primary and secondary packaging for all drug products including ultra-low temperature drug products and specialised kit assembly. Almac was one of the 1st EU CDMOs to support gene therapy product launches, and currently supports 25% of EU approved/pre-registration Gene Therapy solutions. We provide end-to-end management of drug product supply, including distribution, packaging design, and support initial and ongoing global product launch. We provide unique, tailormade solutions designed to support the efficient and successful development, and commercialisation of new treatment options. Partnering with our clients to provide flexible, stable, ongoing supply to meet their product pipeline needs. | The Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. A privately owned organisation, under the McClay Foundation, Almac has grown organically over the past five decades, now employing over 7,500 highly skilled individuals across 18 locations in Europe, the US and Asia. Almac Group is comprised of 5 Business Units: • Almac Diagnostic Services • Almac Sciences • Almac Pharma Services • Almac Clinical Services • Almac Clinical Technologies Each Business Unit offers specialist and dedicated solutions at each phase of the product lifecycle providing the ability to select single or multiple, integrated solutions to meet your unique needs. Our unique combination of inspirational people, exceptional innovation and outstanding quality, enables us to provide tailored solutions for your specific requirements – either on a single, standalone project or on a long-term basis as your strategic partner. About Almac Pharma Services: With over 55 years’ experience, Almac Pharma Services is an established, reliable and world leading outsourcing partner to the global pharmaceutical and biotechnology industry. Employing over 1,800 highly skilled individuals across 4 locations in Europe and the US, we provide a range of tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution. Currently supporting client portfolios across more than 70 countries, our fully integrated, end-to-end solutions are tailored to meet the needs of your unique products, and, ultimately, your patients. Pharmaceutical Development Solutions: Spanning both early and late phase development, our teams of expert scientists possess a wealth of experience in developing clinical candidates into optimal formulations and manufacturing high-quality oral dose products for all phases of clinical trials. Operating both non-GMP and GMP facilities we have complementary equipment trains and integrated technical teams to facilitate technology transfer providing a seamless transition between formulation and process development, and clinical trial material manufacturing. Through a range of flexible and fully tailored unit operations including blending, roller compaction, high shear granulation, encapsulation (including Xcelodose) micro encapsulation and fluid bed processing, we offer the following oral dose formulations with batch sizes ranging from grams to tons: • API / powder in hard gelatin capsules or bottles, including micro-dosing • Formulated blends in hard gelatin capsules or bottles • Tablets (coated) • Mini-tablets • Granules • Beads/pellets • Non-sterile liquid in capsules or bottles • Immediate and modified release • Fixed dose combination products • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug development expertise Analytical Solutions: We employ over 700 highly skilled analysts working in state-of-the-art, fully certified GMP laboratories across Europe and the US with significant experience in the analysis of both small and large molecules. We support drug substance (API) and drug product (finished product) analytics across all phases of clinical development through to commercial release. We offer a range of tailored services including: • Method development • Method validation • Method transfer • Stability programmes • Release analysis: all lifecycle stages • Spectroscopy services • Investigational analysis • Reference standard management • Microbiological testing • Physical sciences • Bio-pharmaceutical testing • Analytical support for clinical trial supplies Commercial Manufacture Solutions: Scaling up from our oral dose development assets and expertise through registration and launch into commercial supply, or transferring existing commercial products, we support your commercial manufacturing needs with flexibility and expertise. With blend sizes from 10kgs up to 2.5 tons, our range of state-of-the-art processing equipment is designed to enable scalability to the batch size requirements of your product for a range of presentations including: • Tablets • Mini-tablets • Capsules • Powders • Granules • Beads/pellets • Non-sterile liquids • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug manufacturing expertise Commercial Packaging Solutions: Our high and low throughput operations provide the flexibility and efficiency necessary to meet your ongoing and fluctuating demand. Our commercial facilities in Europe and the US, combined with our local expertise offers flexible, quality-led commercial pharmaceutical packaging solutions tailored to meet your specific needs. Our range of primary packaging solutions include: • Tablets • Mini-tablets • Capsules • Powders • Granules • Non-sterile liquid • Our secondary packaging, labelling and assembly capabilities include: • Bottles Vials / ampoules • Pre-filled syringes • Wallets / blister cards • Auto-injectors • Cartons • Sachets • Stick packs • Offline blister printing Innovative, specialist packaging solutions including: • Specialist paediatric drug packaging expertise • Expert cell and gene therapy (ATMP) Ultra Low Temperature (ULT) solutions (-20° to -80°) • Complex medical kit assembly solutions via our unique, custom built semi-automated packaging technology Support Solutions: We provide a wide range of tailored support and consultancy services to help guide you through every aspect of your unique development and commercialisation journey. Find out more – www.almacgroup.com
ALLTRISTA PLASTICS
Alltrista Plastics LLC specializes in innovative, high-volume, precision manufacturing for the medical, consumer packaging, and high-end industrial markets. With five locations worldwide, we use proprietary engineering processes and extensive manufacturing capabilities to design innovations the world needs now. From the first spark of an idea, through the design of the mold, to the actual manufactured product, we focus all efforts on creating superior solutions for our customers. This foundation gives us the incredible ability to integrate material science, machine, and automation manufacturing technologies for exceptional results. Pushing the boundaries of sustainable solutions for our customers are our core team of employees who live out our Alltrista values each and every day: Count on Me, Play to Win, and Positively Impacting Lives. Come join our family. | Alltrista’s innovations are everywhere. We make a variety of solutions for pharmaceutical, consumer health, and industrial applications, including high-quality medicine bottles and certified child-resistant caps that give parents peace of mind. Building on deep experience, Alltrista’s material scientists listen to our clients’ needs to quickly and constantly refine and optimize the tools of the trade. Our unique ability to rally strong teams around projects allows us to be agile with even the most demanding tasks. We reimagine manufacturing processes to give our clients unprecedented solutions. This is what makes Alltrista’s products and partnerships exceptional, and what keeps our clients coming back. This is how we make a material difference every day. | At Alltrista, we want to help bring your ideas to life from concept through commercialization. Our goal is to optimize and innovate across every industry and provde the service that you need for your product. We offer a cohesive lineup of stock rigid packaging products and services related to design, tooling & automation, cleanroom manufacturing, injection molding, compression blow forming, automated assembly, filling and kit packing across a variety of industries.
Alida Biosciences
At Alida Biosciences, we develop cutting‑edge tools for RNA modification‑based discovery, diagnostics, therapeutics, and biotechnological applications. Our mission is to empower the evaluation of RNA code beyond primary sequence. Built on deep expertise in protein engineering and enzymology, our innovative technologies position us as leaders in epitranscriptomic tools development. Our products enable highly sensitive RNA modification detection and quantification through a simple workflow and integrated bioinformatics pipeline—empowering confident exploration of complex biological mechanisms from early research to clinical breakthroughs.
Akumin
Akumin is redefining access to advanced imaging and radiation oncology across the U.S. Through a coast-to-coast network of outpatient centers, the nation’s largest mobile imaging fleet, and its innovative Akumin AXIS relocatable clinics, Akumin empowers hospitals and health systems to expand capacity without compromise. Trusted by more than 800 healthcare partners, Akumin blends clinical expertise, operational precision, and cutting-edge technology to deliver smarter, faster, and more connected patient care.
Aikenist Technologies
A Fast-growing AI MedTech Company specializing in providing end-to-end AI-based Software Solutions for the Radiology Community. From Appointment, Billing, Fast Scanning, AI-based Diagnosis, Gen AI Reporting and Intervention, we have it all! Our Flagship product, Aiken QuickScan, enhances MRI Image from an old MRI Machine, saving time and cost by upto 70%. FDA, ANVISA, ISO, CDSCO Certified! Over 800 installations, worldwide!